ArticleInternational journal of hematology2023

Synergistic effect of combined PI3 kinase inhibitor and PARP inhibitor treatment on BCR/ABL1-positive acute lymphoblastic leukemia cells.

Haruka Hiroki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.